| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KALV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 100.0K | $2.70M | - | |
| Other | 51.4K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 4,466 | $14.48 | $64,665.00 | -1.1% | +5.0% | - | |
| Nov 18, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 2,683 | $14.48 | $38,848.23 | -2.0% | +5.0% | - | |
| Nov 18, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 3,075 | $14.48 | $44,524.46 | -2.4% | +5.0% | - | |
| Nov 12, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 3,328 | $11.55 | $38,438.40 | -0.8% | +12.5% | - | |
| Sep 8, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 7,294 | $15.84 | $115,536.96 | -1.8% | +5.6% | - | |
| Aug 25, 2025 | Sweeny Nicole | Chief Commercial Officer | Sale+OE | 1,480 | $13.42 | $19,861.60 | -4.4% | +2.8% | - | |
| Aug 25, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 1,954 | $13.42 | $26,222.68 | -1.5% | +2.8% | - | |
| Aug 25, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 2,336 | $13.42 | $31,349.12 | -1.9% | +2.8% | - | |
| Aug 22, 2025 | Sweeny Nicole | Chief Commercial Officer | Sale+OE | 1,864 | $13.22 | $24,647.30 | -6.1% | -2.9% | - | |
| Aug 22, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 2,362 | $13.22 | $31,232.25 | -1.8% | -2.9% | - |